Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
105.80
-0.58 (-0.55%)
At close: May 13, 2025, 3:59 PM
105.63
-0.16%
After-hours: May 13, 2025, 04:20 PM EDT
-0.55% (1D)
| Bid | 90 |
| Market Cap | 2.04B |
| Revenue (ttm) | 167.13M |
| Net Income (ttm) | -4.03M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -480.91 |
| Forward PE | 14.82 |
| Analyst | Buy |
| Ask | 110 |
| Volume | 118,035 |
| Avg. Volume (20D) | 122,177 |
| Open | 106.38 |
| Previous Close | 106.38 |
| Day's Range | 104.67 - 107.81 |
| 52-Week Range | 77.43 - 129.90 |
| Beta | 0.76 |
About LGND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LGND
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LGND stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Ligand Pharmaceuticals has released their quartely earnings
on May 8, 2025:
2 months ago
+0.57%
Ligand Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
6 months ago
+11.12%
Ligand Pharmaceuticals shares are trading higher after the company reported worse-than-expected Q3 financial results and raised its FY24 guidance.
2 months ago · seekingalpha.com
Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call TranscriptLigand Pharmaceuticals Incorporated (NASDAQ:LGND ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Melanie Herman - Senior Director of Financial Planning and Analysi...